362 related articles for article (PubMed ID: 33405316)
1. Multifunctional intracellular matrix metalloproteinases: implications in disease.
Bassiouni W; Ali MAM; Schulz R
FEBS J; 2021 Dec; 288(24):7162-7182. PubMed ID: 33405316
[TBL] [Abstract][Full Text] [Related]
2. Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease.
Ali MA; Fan X; Schulz R
Trends Cardiovasc Med; 2011 May; 21(4):112-8. PubMed ID: 22681966
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibitor properties of tetracyclines: therapeutic potential in cardiovascular diseases.
Castro MM; Kandasamy AD; Youssef N; Schulz R
Pharmacol Res; 2011 Dec; 64(6):551-60. PubMed ID: 21689755
[TBL] [Abstract][Full Text] [Related]
4. Myocardial matrix metalloproteinase-2: inside out and upside down.
DeCoux A; Lindsey ML; Villarreal F; Garcia RA; Schulz R
J Mol Cell Cardiol; 2014 Dec; 77():64-72. PubMed ID: 25261607
[TBL] [Abstract][Full Text] [Related]
5. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localization of matrix metalloproteinases.
Mannello F; Medda V
Prog Histochem Cytochem; 2012 Mar; 47(1):27-58. PubMed ID: 22226510
[TBL] [Abstract][Full Text] [Related]
7. Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.
Cauwe B; Opdenakker G
Crit Rev Biochem Mol Biol; 2010 Oct; 45(5):351-423. PubMed ID: 20812779
[TBL] [Abstract][Full Text] [Related]
8. Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke RE; Libert C
Nat Rev Drug Discov; 2014 Dec; 13(12):904-27. PubMed ID: 25376097
[TBL] [Abstract][Full Text] [Related]
9. Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology.
de Almeida LGN; Thode H; Eslambolchi Y; Chopra S; Young D; Gill S; Devel L; Dufour A
Pharmacol Rev; 2022 Jul; 74(3):712-768. PubMed ID: 35738680
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases.
Zitka O; Kukacka J; Krizkova S; Huska D; Adam V; Masarik M; Prusa R; Kizek R
Curr Med Chem; 2010; 17(31):3751-68. PubMed ID: 20846107
[TBL] [Abstract][Full Text] [Related]
11. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature.
Chow AK; Cena J; Schulz R
Br J Pharmacol; 2007 Sep; 152(2):189-205. PubMed ID: 17592511
[TBL] [Abstract][Full Text] [Related]
12. Activation and silencing of matrix metalloproteinases.
Fu X; Parks WC; Heinecke JW
Semin Cell Dev Biol; 2008 Feb; 19(1):2-13. PubMed ID: 17689277
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
[TBL] [Abstract][Full Text] [Related]
14. Matrix Metalloproteinases in Non-Neoplastic Disorders.
Tokito A; Jougasaki M
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455234
[TBL] [Abstract][Full Text] [Related]
15. [The role of matrix metalloproteinases in cardiovascular diseases].
Groblewska M; Tycińska A; Mroczko B; Musiał W; Szmitkowski M
Pol Merkur Lekarski; 2011 Apr; 30(178):235-40. PubMed ID: 21595165
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and Biological Attributes of Matrix Metalloproteinases.
Cui N; Hu M; Khalil RA
Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations.
Castro MM; Tanus-Santos JE
Curr Drug Targets; 2013 Mar; 14(3):335-43. PubMed ID: 23316965
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases at a glance.
Hey S; Linder S
J Cell Sci; 2024 Jan; 137(2):. PubMed ID: 38236162
[TBL] [Abstract][Full Text] [Related]
19. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
Narula S; Tandon C; Tandon S
Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
[TBL] [Abstract][Full Text] [Related]
20. New intracellular activities of matrix metalloproteinases shine in the moonlight.
Jobin PG; Butler GS; Overall CM
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):2043-2055. PubMed ID: 28526562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
